Extended-release Naltrexone and Case Management for Treatment of Alcohol Used Disorder in the Emergency Department

被引：0
作者：
Murphy, C. [1 ]
Wang, R. [1 ]
Montoy, J. C. [1 ]
Coralic, Z. [1 ]
Ramirez, B. [1 ]
Raven, M. [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA USA
来源：
ANNALS OF EMERGENCY MEDICINE | 2022年 / 80卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
6
引用
收藏
页码：S3 / S3
页数：1
相关论文
共 50 条
  • [21] Extended-Release Intramuscular Naltrexone
    Tracy Swainston Harrison
    Greg L. Plosker
    Susan J. Keam
    [J]. Drugs, 2006, 66 : 1741 - 1751
  • [22] Injectable Extended-Release Naltrexone Effective for Opioid Use Disorder
    Slawson, David C.
    [J]. AMERICAN FAMILY PHYSICIAN, 2018, 97 (12) : 819 - 819
  • [23] EXTENDED-RELEASE VS. ORAL NALTREXONE FOR ALCOHOL DEPENDENCE TREATMENT IN PRIMARY CARE
    Malone, M.
    Vittitow, A.
    McDonald, R. D.
    Tofighi, B.
    Garment, A.
    Schatz, D.
    Laska, E.
    Goldfeld, K.
    Rotrosen, J.
    Lee, J. D.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 42 : 64A - 64A
  • [24] Extended-Release Naltrexone Injectable Suspension for Treatment of Alcohol Dependence in Urban Primary Care
    Lee, J. D.
    Grossman, E.
    DiRocco, D.
    Truncali, A.
    Rotrosen, J.
    Stevens, D.
    Gourevitch, M. N.
    [J]. SUBSTANCE ABUSE, 2009, 30 (01) : 85 - 85
  • [25] EXTENDED-RELEASE VS. ORAL NALTREXONE FOR ALCOHOL DEPENDENCE TREATMENT IN PRIMARY CARE
    Malone, M.
    Vittitow, A.
    McDonald, R. D.
    Tofighi, B.
    Garment, A.
    Schatz, D.
    Laska, E.
    Goldfeld, K.
    Rotrosen, J.
    Lee, J. D.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2019, 43 : 248A - 248A
  • [26] Extended-release vs. oral naltrexone for alcohol dependence treatment in primary care
    Chen, Jenny
    McDonald, Ryan D.
    Obi, Rita
    Wong, Shadae
    Flannery, Mara
    Tofighi, Babak
    Kermack, Andrea
    Rotrosen, John
    Gourevitch, Marc
    Lee, Joshua D.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2017, 171 : E39 - E39
  • [27] An update on naltrexone/bupropion extended-release in the treatment of obesity
    Saunders, Katherine H.
    Igel, Leon I.
    Aronne, Louis J.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (16) : 2235 - 2242
  • [28] Impact on Counseling and Recovery Activities of Alcohol Dependence Treatment with Injectable Extended-Release Naltrexone
    Gromov, I.
    Kaempf, G.
    Silverman, B.
    Gastfriend, D. R.
    Cisler, R.
    [J]. SUBSTANCE ABUSE, 2009, 30 (02) : 192 - 193
  • [29] DETERMINANTS OF AN EFFICIENT MODEL OF EXTENDED-RELEASE NALTREXONE INITIATION FOR THE TREATMENT OF OPIOID USE DISORDER
    Murphy, S.
    McCollister, K. E.
    Jeng, P.
    Leff, J.
    Lee, J. D.
    Nunes, E., V
    Novo, P.
    Rotrosen, J.
    Schackman, B. R.
    [J]. VALUE IN HEALTH, 2019, 22 : S175 - S175
  • [30] Pain intensity in patients using extended-release naltrexone or opioid agonists and its effect on extended-release naltrexone treatment outcomes
    Juya, Farid
    Solli, Kristin K.
    Holtan, Line
    Sannes, Ann-Christin
    Weimand, Bente
    Sagen, Anne G.
    Benth, Jurate S.
    Gjerstad, Johannes
    Tanum, Lars
    Mordal, Jon
    [J]. AMERICAN JOURNAL ON ADDICTIONS, 2025,
12345